Kiranya E Tipirneni1, Bradford A Woodworth2. 1. Department of Surgery, University of Alabama at Birmingham. 2. Department of Otolaryngology, University of Alabama at Birmingham.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to provide otolaryngologists with the most up-to-date advancements in both the medical and surgical management of CF-related sinus disease. RECENT FINDINGS: Recent studies have supported more aggressive CRS management, often with a combination of both medical and surgical therapies. Comprehensive treatment strategies have been shown to reduce hospital admissions secondary to pulmonary exacerbations in addition to improving CRS symptoms. Still, current management strategies are lacking in both high-level evidence and standardized guidelines. SUMMARY: The unified airway model describes the bi-directional relationship between the upper and lower airways as a single functional unit and suggests that CRS may play a pivotal role in both the development and progression of lower airway disease. Current strategies for CF CRS focus primarily on amelioration of symptoms with antibiotics, nasal saline and/or topical medicated irrigations, and surgery. However, there are no definitive management guidelines and there remains a persistent need for additional studies. Nevertheless, otolaryngologists have a significant role in the overall management of CF, which requires a multi-disciplinary approach and a combination of both surgical and medical interventions for optimal outcomes of airway disease. Here we present a review of currently available literature and summarize medical and surgical therapies best suited for the management of CF-related sinus disease.
PURPOSE OF REVIEW: The purpose of this review is to provide otolaryngologists with the most up-to-date advancements in both the medical and surgical management of CF-related sinus disease. RECENT FINDINGS: Recent studies have supported more aggressive CRS management, often with a combination of both medical and surgical therapies. Comprehensive treatment strategies have been shown to reduce hospital admissions secondary to pulmonary exacerbations in addition to improving CRS symptoms. Still, current management strategies are lacking in both high-level evidence and standardized guidelines. SUMMARY: The unified airway model describes the bi-directional relationship between the upper and lower airways as a single functional unit and suggests that CRS may play a pivotal role in both the development and progression of lower airway disease. Current strategies for CF CRS focus primarily on amelioration of symptoms with antibiotics, nasal saline and/or topical medicated irrigations, and surgery. However, there are no definitive management guidelines and there remains a persistent need for additional studies. Nevertheless, otolaryngologists have a significant role in the overall management of CF, which requires a multi-disciplinary approach and a combination of both surgical and medical interventions for optimal outcomes of airway disease. Here we present a review of currently available literature and summarize medical and surgical therapies best suited for the management of CF-related sinus disease.
Authors: Eugene H Chang; Xiao Xiao Tang; Viral S Shah; Janice L Launspach; Sarah E Ernst; Brieanna Hilkin; Philip H Karp; Mahmoud H Abou Alaiwa; Scott M Graham; Douglas B Hornick; Michael J Welsh; David A Stoltz; Joseph Zabner Journal: Int Forum Allergy Rhinol Date: 2014-10-31 Impact factor: 3.858
Authors: Katherine L Tuggle; Susan E Birket; Xiaoxia Cui; Jeong Hong; Joe Warren; Lara Reid; Andre Chambers; Diana Ji; Kevin Gamber; Kengyeh K Chu; Guillermo Tearney; Li Ping Tang; James A Fortenberry; Ming Du; Joan M Cadillac; David M Bedwell; Steven M Rowe; Eric J Sorscher; Michelle V Fanucchi Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240
Authors: Kiranya E Tipirneni; Jessica W Grayson; Shaoyan Zhang; Do-Yeon Cho; Daniel F Skinner; Dong-Jin Lim; Calvin Mackey; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth Journal: Int Forum Allergy Rhinol Date: 2017-06-28 Impact factor: 3.858
Authors: Justin P McCormick; Christopher G Weeks; Nicholas J Rivers; Jacob D Owen; David R Kelly; Steven M Rowe; George M Solomon; Bradford A Woodworth; Do-Yeon Cho Journal: Int Forum Allergy Rhinol Date: 2019-08-20 Impact factor: 3.858
Authors: Jochen G Mainz; Carlos Zagoya; Louise Polte; Lutz Naehrlich; Lenny Sasse; Olaf Eickmeier; Christina Smaczny; Anton Barucha; Lilith Bechinger; Franziska Duckstein; Ludwik Kurzidim; Patience Eschenhagen; Laura Caley; Daniel Peckham; Carsten Schwarz Journal: Front Pharmacol Date: 2022-06-03 Impact factor: 5.988
Authors: Do-Yeon Cho; Shaoyan Zhang; Daniel F Skinner; Dong Jin Lim; Catherine Banks; Jessica W Grayson; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth Journal: Int Forum Allergy Rhinol Date: 2021-10-26 Impact factor: 5.426
Authors: Zainab Farzal; Kelly M Dean; Satyan B Sreenath; Sarah E Hodge; Brian D Thorp; Charles S Ebert; Adam M Zanation; Brent A Senior; Adam J Kimple Journal: Int Forum Allergy Rhinol Date: 2020-01-17 Impact factor: 3.858